Mucosal irritation testing is a core element of the biological safety evaluation of medical devices, verifying whether products that contact mucosal membranes such as catheters, intrauterine devices, dental appliances, and topical gels provoke local inflammatory responses. The test is performed in accordance with ISO 10993-23:2021 (and its Chinese counterpart GB/T 16886.23), supported by ISO 10993-1 for study planning and ISO 10993-12 for sample preparation. This article explains the technical principles, sample requirements, test procedures, scoring criteria, and typical applications of mucosal irritation studies for global regulatory submissions.
Technical Overview
Mucosal irritation testing evaluates the potential of a medical device, its material, or its extracts to produce local irritation or injury to mucous membranes, including vaginal, oral, urethral, bladder, rectal, and nasal tissues. Within the biological evaluation framework of ISO 10993-1, irritation is classified as a mandatory endpoint for all devices with surface or external communicating contact with mucosal membranes, breached or compromised surfaces, and for devices with prolonged or long-term contact durations.
The current harmonized standard for irritation testing is ISO 10993-23:2021, which superseded the irritation content of ISO 10993-10 and introduces a tiered strategy that prioritizes in vitro methods where scientifically valid, consistent with the 3Rs principle (replacement, reduction, and refinement of animal use). In China, the equivalent national standard GB/T 16886.23 applies. Test articles are prepared in accordance with ISO 10993-12, which specifies extraction media, extraction ratios, and conditioning parameters. Where in vivo testing remains necessary, studies are conducted in compliant facilities such as accredited third-party laboratories operating under GLP or equivalent quality systems.
The fundamental principle of the test is to expose the target mucosal tissue to the test article or its extract under controlled conditions, then evaluate the tissue response using both macroscopic observation (erythema and edema) and microscopic histopathological examination of the exposed mucosa.
Testing Samples
Device Extracts
For most finished devices, extracts are prepared using both a polar medium (such as sodium chloride injection or water) and a non-polar medium (such as cottonseed oil or sesame oil), and if appropriate, additional media including ethanol/water mixtures, polyethylene glycol 400, or dimethyl sulfoxide. Extraction is typically performed at 37°C for 24 hours; alternative conditions such as 50°C for 72 hours, 70°C for 24 hours, or 121°C for 1 hour may be selected to simulate exaggerated or clinically relevant exposure.
Direct-Contact Materials
Materials that cannot be meaningfully extracted, including solid formed plastics, elastomers, ceramics, and large-surface devices, may be tested by direct contact with the mucosal surface. The sample geometry, thickness, and surface area are documented, and extraction ratios follow the mass- or surface-based limits defined in ISO 10993-12.
Liquids, Gels, and Cured Compositions
Liquid and gel products such as lubricants, spermicides, wound gels, and delivery formulations can be dosed directly. Multi-component materials that cure in use, such as dental cements and impression materials, are fully cured before testing so that the final clinical state is evaluated.
Testing Items
The evaluation combines clinical observation with laboratory histopathology, covering the following endpoints:
- Macroscopic scoring of erythema and eschar formation at the exposure site, graded on a 0 to 4 scale
- Macroscopic scoring of edema formation, graded on a 0 to 4 scale
- Histopathological assessment of epithelial integrity, including ulceration, erosion, and thinning of the mucosal epithelium
- Microscopic evaluation of leukocyte infiltration within the mucosa and submucosa
- Microscopic evaluation of vascular congestion and tissue edema
- Comparison of test-article responses against negative and positive controls, with calculation of irritation indices where applicable
Testing Methods
In Vivo Vaginal Mucosal Irritation Test
The rabbit vaginal irritation test is the most widely applied in vivo method. Healthy adult female rabbits are randomly assigned to test, negative control, and, where required, positive control groups. A defined volume of the polar or non-polar extract is instilled into the vaginal vault, or the test material is inserted directly, typically once daily for consecutive exposure periods that reflect the intended clinical contact duration. Following the final exposure, the mucosa is examined macroscopically, and vaginal tissues are collected, fixed, sectioned, and stained for histopathological evaluation.
Oral and Buccal Mucosa Tests
For devices contacting the oral cavity, such as denture bases, orthodontic appliances, and oral hygiene products, extracts may be applied to the buccal or labial mucosa of rabbits, or the hamster cheek pouch model may be used for direct material contact. Scoring follows the same erythema, edema, and histopathology endpoints.
Bladder, Rectal, and Other Mucosal Sites
Urological devices such as urinary catheters and bladder instillation products may require a rabbit bladder irritation model, in which extracts are instilled intraluminally and the urothelium is subsequently examined. Rectal devices and suppository-type products are evaluated using analogous site-specific protocols justified by the intended use.
In Vitro Alternative Methods
In line with ISO 10993-23 and the 3Rs principle, reconstructed human epithelial models, including vaginal, oral, and ocular tissue models validated under frameworks such as OECD Test Guidelines, are increasingly accepted as screening or standalone methods when justified by a chemical characterization and risk assessment. Regulatory authorities, including those following FDA and EU MDR expectations, encourage a documented rationale for the chosen strategy.
Scoring and Interpretation
Macroscopic reactions are scored immediately after exposure and at defined observation times, with scores recorded separately for each animal and each site. Histopathological grading covers epithelial changes, leukocyte infiltration, vascular congestion, and edema. The test article is generally considered a mucosal irritant when the observed response, either macroscopic or microscopic, clearly exceeds that of the negative control and the difference is biologically and statistically meaningful. Results are interpreted together with cytotoxicity, sensitization, and chemical characterization data as part of the overall biological risk assessment.
Applications
Mucosal irritation testing supports biological safety documentation for a broad range of product categories:
- Urological devices, including urinary catheters, urethral stents, and bladder irrigation products
- Gynecological devices, including intrauterine devices, vaginal rings, condoms, diaphragms, and tampons
- Oral and dental products, including denture materials, orthodontic wires and brackets, dental cements, and mouth rinses
- Enteral and respiratory devices, including feeding tubes, endotracheal tubes, and laryngeal mask airways
- Nasal and otic delivery devices, sprays, and drops contacting mucosal tissue
- Topical liquids, gels, lubricants, and semi-solid formulations applied to mucosal surfaces
- Regulatory submissions for NMPA, FDA, CE marking under the EU MDR, and other market authorizations requiring ISO 10993 biological evaluation reports
FAQ
When is mucosal irritation testing required?
It is required for devices whose intended use involves contact with intact mucosal membranes or breached surfaces, particularly for contact durations exceeding 24 hours (prolonged contact) or for repeated and long-term exposure. The exact requirement is determined by the ISO 10993-1 endpoint matrix and the documented biological risk assessment for the specific device.
Which standard should the study follow?
Irritation testing is conducted under ISO 10993-23:2021, with sample preparation per ISO 10993-12 and study planning per ISO 10993-1. In China, the accepted national equivalents are GB/T 16886.23 and GB/T 16886.12.
Can in vitro testing replace animal studies?
For skin irritation, validated in vitro methods are now the default. For mucosal irritation, reconstructed human epithelium models may be acceptable as screening tools or, with adequate scientific justification and chemical characterization data, as alternatives to animal testing. Regulators review the justification case by case.
What sample quantities are typically needed?
Requirements depend on the device geometry and extraction ratio, but a common preparation provides sufficient material for both polar and non-polar extraction at the ratios specified in ISO 10993-12, plus retained samples for control and repeat testing. Sterile, finished, representative production samples should be submitted whenever possible.
How long does the study take?
Typical in vivo vaginal or oral mucosal studies, including exposure period, necropsy, histopathology, and reporting, are completed within four to eight weeks after sample acceptance, depending on the protocol, number of groups, and use-site simulation requirements.
How are results used in regulatory submissions?
Results are integrated into the biological evaluation report and the overall risk management file. A non-irritant conclusion supports claims of mucosal safety, while irritant findings trigger material reformulation, design changes, or labeling restrictions in accordance with ISO 14971 risk management principles.